A Thabaut

548 total citations
76 papers, 395 citations indexed

About

A Thabaut is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology. According to data from OpenAlex, A Thabaut has authored 76 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Medicine, 38 papers in Pharmacology and 28 papers in Applied Microbiology and Biotechnology. Recurrent topics in A Thabaut's work include Antibiotic Resistance in Bacteria (46 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers) and Antibiotic Use and Resistance (28 papers). A Thabaut is often cited by papers focused on Antibiotic Resistance in Bacteria (46 papers), Antibiotics Pharmacokinetics and Efficacy (34 papers) and Antibiotic Use and Resistance (28 papers). A Thabaut collaborates with scholars based in France, Morocco and Germany. A Thabaut's co-authors include M Meyran, A. Philippon, B. Fantin, C Carbon, Robert Farinotti, Philippe Saliou, George A. Jacoby, R Cluzel, J. F. Acar and Claude–James Soussy and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

A Thabaut

67 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Thabaut France 11 208 173 126 86 66 76 395
M Meyran France 9 229 1.1× 108 0.6× 136 1.1× 104 1.2× 68 1.0× 63 414
D. Hoban Canada 11 161 0.8× 114 0.7× 180 1.4× 109 1.3× 46 0.7× 12 400
R R Packer United States 11 189 0.9× 208 1.2× 187 1.5× 119 1.4× 54 0.8× 22 418
Jacques Dubois Canada 13 127 0.6× 119 0.7× 225 1.8× 91 1.1× 45 0.7× 27 447
C. A. DiVincenzo United States 10 308 1.5× 197 1.1× 103 0.8× 94 1.1× 139 2.1× 12 563
M.O. Husson France 10 202 1.0× 119 0.7× 156 1.2× 51 0.6× 61 0.9× 30 426
Harriette Nadler United States 11 123 0.6× 145 0.8× 92 0.7× 125 1.5× 45 0.7× 20 340
H. Drugeon France 10 147 0.7× 208 1.2× 136 1.1× 94 1.1× 58 0.9× 37 481
Nai‐Xun Chin United States 11 146 0.7× 153 0.9× 183 1.5× 40 0.5× 50 0.8× 26 388
C. J. Henwood United Kingdom 7 281 1.4× 115 0.7× 110 0.9× 164 1.9× 96 1.5× 7 462

Countries citing papers authored by A Thabaut

Since Specialization
Citations

This map shows the geographic impact of A Thabaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Thabaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Thabaut more than expected).

Fields of papers citing papers by A Thabaut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Thabaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Thabaut. The network helps show where A Thabaut may publish in the future.

Co-authorship network of co-authors of A Thabaut

This figure shows the co-authorship network connecting the top 25 collaborators of A Thabaut. A scholar is included among the top collaborators of A Thabaut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Thabaut. A Thabaut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldstein, F. W., Claude–James Soussy, & A Thabaut. (1996). Definition of the Clinical Antibacterial Spectrum of Activity. Clinical Microbiology and Infection. 2. S40–S45. 13 indexed citations
2.
Carsenti-Etesse, H., et al.. (1995). In Vitro Development of Resistance of Streptococcus pneumoniae to β-Lactam Antibiotics. Microbial Drug Resistance. 1(1). 85–94. 10 indexed citations
3.
Thabaut, A, J Avril, Cécile Bébéar, et al.. (1995). Evolution de la sensibilité des bacilles à Gram négatif à la ceftazidime et à trois autres bêta-lactamines en milieu hospitalier de 1989 à 1993. Médecine et Maladies Infectieuses. 25. 6–19. 3 indexed citations
4.
Fantin, B., Robert Farinotti, A Thabaut, & C Carbon. (1994). Conditions for the emergence of resistance to cefpirome and ceftazidime in experimental endocarditis due to Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 33(3). 563–569. 44 indexed citations
5.
Carsenti-Etesse, H., J. Durant, Fernando Salvador, et al.. (1994). Possible prevention of in vitro selection of resistantStreptococcus pneumoniae by beta-lactamase inhibitors. European Journal of Clinical Microbiology & Infectious Diseases. 13(12). 1058–1062. 4 indexed citations
6.
Duval, J, C J Soussy, J. F. Acar, et al.. (1993). In-vitro antibacterial activity of cefepime: a multicentre study. Journal of Antimicrobial Chemotherapy. 32(suppl B). 55–61. 24 indexed citations
7.
Soussy, Claude–James, J. F. Acar, R Cluzel, et al.. (1992). A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France. Journal of Antimicrobial Chemotherapy. 30(suppl A). 53–58. 26 indexed citations
8.
Labia, Roger, A Thabaut, A Morand, et al.. (1989). The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.. PubMed. 15(11-12). 535–40. 2 indexed citations
9.
Thabaut, A & M Meyran. (1989). Etat actuel et evolution de la sensibilite des enterobacteries a la ceftriaxone. Médecine et Maladies Infectieuses. 19. 31–38.
10.
Thabaut, A, Marie Chanal, A Buré, et al.. (1989). [In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study].. PubMed. 37(5 Pt 2). 528–33. 2 indexed citations
11.
Péan, Y., A Thabaut, M Meyran, et al.. (1987). [Characteristics of penicillinase-producing strains of Neisseria gonorrhoeae isolated in France, 1979-1986].. PubMed. 35(5 Pt 2). 791–5. 2 indexed citations
12.
Thabaut, A. (1987). Sensibilite aux antibiotiques des bacteries pathogenes chez l'enfant en Afrique. Médecine et Maladies Infectieuses. 17(4). 192–197. 1 indexed citations
13.
Modaï, J & A Thabaut. (1986). [Antibiotic therapy of Pseudomonas aeruginosa infections].. PubMed. 15(30). 1417–20. 1 indexed citations
14.
Thabaut, A, M Meyran, & Michel Huerre. (1985). Evolution and present situation of Staphylococcus aureus sensitivity to MLS in hospital (1975-83). Journal of Antimicrobial Chemotherapy. 16(suppl A). 205–207. 9 indexed citations
15.
Thabaut, A. (1984). [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations].. PubMed. 38(4). 399–404. 1 indexed citations
16.
Deforges, Lionel, C J Soussy, J Duval, et al.. (1983). [Multicenter study of the in vitro antibacterial activity of ceftazidime on gram-negative bacilli].. PubMed. 31(5). 375–8. 1 indexed citations
17.
Thabaut, A, et al.. (1982). [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].. PubMed. 30(6). 394–7. 18 indexed citations
19.
Thabaut, A, et al.. (1979). [Polymorphic histological changes in a case of angio-immunoblastic adenopathy (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 130(11). 541–5. 2 indexed citations
20.
Thabaut, A, et al.. (1976). Non functional malignant nesidioblastoma. About one case (author's transl).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(6-7). 527–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026